Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
Circulating miRNAs (microRNAs) are emerging as promising biomarkers for several pathological conditions, and the aim of this study was to investigate the feasibility of using serum miRNAs as biomarkers for liver pathologies. Real-time qPCR (quantitative PCR)-based TaqMan MicroRNA arrays were first employed to profile miRNAs in serum pools from patients with HCC (hepatocellular carcinoma) or LC (liver cirrhosis) and from healthy controls. Five miRNAs (i.e. miR-885-5p, miR-574-3p, miR-224, miR-215 and miR-146a) that were up-regulated in the HCC and LC serum pools were selected and further quantified using real-time qPCR in patients with HCC, LC, CHB (chronic hepatitis B) or GC (gastric cancer) and in normal controls. The present study revealed that more than 110 miRNA species in the serum samples and wide distribution ranges of serum miRNAs were observed. The levels of miR-885-5p were significantly higher in sera from patients with HCC, LC and CHB than in healthy controls or GC patients. miR-885-5p yielded an AUC [the area under the ROC (receiver operating characteristic) curve] of 0.904 [95% CI (confidence interval), 0.837-0.951, P<0.0001) with 90.53% sensitivity and 79.17% specificity in discriminating liver pathologies from healthy controls, using a cut off value of 1.06 (normalized). No correlations between increased miR-885-5p and liver function parameters [AFP (α-fetoprotein), ALT (alanine aminotransferase), AST (aspartate aminotransferase) and GGT (γ-glutamyl transpeptidase)] were observed in patients with liver pathologies. In summary, miR-885-5p is significantly elevated in the sera of patients with liver pathologies, and our data suggest that serum miRNAs could serve as novel complementary biomarkers for the detection and assessment of liver pathologies.
Gui
Junhao
J
Department of Clinical Biochemistry, Chinese PLA General Hospital, 28 Fuxing Rd, Beijing 100853, People's Republic of China.
Tian
Yaping
Y
Wen
Xinyu
X
Zhang
Wenhui
W
Zhang
Pengjun
P
Gao
Jing
J
Run
Wei
W
Tian
Liyuan
L
Jia
Xingwang
X
Gao
Yanhong
Y
D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis; D004812:Epidemiologic Methods; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis; D008107:Liver Diseases / Q000175:diagnosis*; D008113:Liver Neoplasms / Q000175:diagnosis; D008297:Male; D035683:MicroRNAs / Q000097:blood*; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods; D012334:RNA, Neoplasm / Q000097:blood; D015854:Up-Regulation
D015415:Biomarkers; D014408:Biomarkers, Tumor; D035683:MicroRNAs; D012334:RNA, Neoplasm
Ann Surg. 2010 Mar;251(3):499-505
20134314
Gynecol Oncol. 2009 Jan;112(1):55-9
18954897
Eur J Cancer. 2010 Apr;46(6):1056-61
20202823
PLoS One. 2009;4(5):e5532
19440243
Cancer Prev Res (Phila). 2009 Sep;2(9):807-13
19723895
Nat Protoc. 2008;3(6):1101-8
18546601
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4402-7
19246379
Br J Haematol. 2008 May;141(5):672-5
18318758
Clin Chim Acta. 2008 Mar;389(1-2):146-51
18179774
Nat Protoc. 2006;1(3):1154-9
17406397
Oncogene. 2006 Apr 20;25(17):2537-45
16331254
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
18663219
Hepatology. 2008 Dec;48(6):2047-63
19003900
Clin Sci (Lond). 2010 Apr 20;119(2):87-95
20218970
Clin Chem. 2009 Nov;55(11):1944-9
19696117
Hepatology. 2006 Feb;43(2 Suppl 1):S145-50
16447291
J Infect. 2009 May;58(5):383-8
19329189
Lab Invest. 2009 May;89(5):597-606
19290006
Am J Pathol. 2008 Sep;173(3):856-64
18688024
Nature. 2005 Jun 9;435(7043):834-8
15944708
Cell. 2009 Jan 23;136(2):215-33
19167326
J Lipid Res. 2009 Sep;50(9):1756-65
19372595
Hepatology. 2008 Jun;47(6):1955-63
18433021
Intervirology. 2008;51 Suppl 1:42-5
18544947
Cell Res. 2008 Oct;18(10):997-1006
18766170
JAMA. 2008 Jan 30;299(4):425-36
18230780
Gut. 2009 Oct;58(10):1375-81
19201770
BMC Res Notes. 2009 May 19;2:89
19454029
Methods. 2001 Dec;25(4):402-8
11846609
Nucleic Acids Res. 2008 Dec;36(21):e143
18940866
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5330-5
19289845
Int J Cancer. 2008 Oct 1;123(7):1616-22
18649363
J Clin Oncol. 2010 Apr 1;28(10):1721-6
20194856
Clin Chem. 2010 Jul;56(7):1183-5
20395621